- Condition: Leukemia
Interventions: Drug: Cladribine; Drug: Cytarabine; Drug: Decitabine
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified February 2012 - Conditions: Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Burkitts Leukemia/Lymphoma; Chronic Myelogenous Leukemia
Interventions: Drug: CLAG-M; Drug: CLAG-M
Sponsors: New York Medical College; New York Medical College
Recruiting - verified January 2012 - Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab; Drug: bortezomib; Drug: Cladribine
Sponsors: Penn State University; Penn State University
Not yet recruiting - verified September 2011 - Conditions: Severe Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Myeloproliferative Syndromes; Chronic Myelogenous Leukemia; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Large Granulocytic Leukemia
Intervention: Procedure: Allogeneic transplantation
Sponsors: Scripps Health; Scripps Health
Recruiting - verified June 2011 - Condition: Leukemia, Myeloid, Acute
Interventions: Drug: CLAG + ATRA + Midostaurin 25 mg; Drug: CLAG + ATRA + Midostaurin 50 mg
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified September 2011 - Condition: Multiple Sclerosis
Intervention:
Sponsors: EMD Serono; EMD Serono
Recruiting - verified July 2011 - Condition: Lymphoma
Interventions: Drug: rituximab; Drug: bortezomib; Drug: cladribine
Sponsors: University of Arizona; University of Arizona; National Cancer Institute (NCI)
Recruiting - verified June 2011 - Condition: Hairy Cell Leukemia
Interventions: Drug: Cladribine; Drug: Rituximab
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Leukemia; Lymphoma
Interventions: Biological: rituximab; Drug: cladribine; Drug: vorinostat; Other: laboratory biomarker analysis
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Leukemia
Interventions: Drug: Cladribine; Drug: Rituximab
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Genentech
Recruiting - verified May 2012
 |
Cladribine Clinical Trials |
